Dr. Robin Smith

Dr. Smith is Chairman of the Board of Directors and Chief Executive Officer of NeoStem, Inc., (NYSE AMEX:NBS) an adult stem cell collection processing and long term storage company. She is also a managing director of the Madelin Fund. Prior to this position, Dr. Smith has acted as a senior advisor and investor to both private and publicly traded companies where she has played a significant role in restructuring and or growing the companies. Additionally, she assisted multiple investment banks where she evaluated companies in healthcare, media and emerging technologies. Dr. Smith also serves on the Board of Trustees of the NYU Medical Center Board and is Chairman of the Board of Directors for the New York University Hospital for Joint Diseases where she heads up new development efforts and board member recruitment. She has also served on the Chemotherapy Foundation Board of Trustees, The New York Theatre Ballet board, the Choose Living board of directors and the board of Talon Air.

Prior to these activities, Dr. Smith served as President & Chief Executive Officer of IP2M. During her term, the company was selected as being one of the 10 fastest growing technology companies in Houston. IP2M was sold to a publicly traded company in February of 2003. Before joining the IP2M management team, Dr. Smith was Executive Vice President & Chief Medical Officer for HealthHelp, Inc., a National Radiology Management company which managed 14% of the health care dollars spent by insurance companies such as Aetna, Blue Cross and Blue Shield, and Humana.

Dr. Smith received her post-graduate training in surgery at the Thomas Jefferson University Hospital and obtained her medical degree from Yale University where she received the Janet M. Glaslow Memorial Achievement Citation, was elected to Alpha Omega Alpha and chosen to be a Farr Scholar. Dr. Smith was one of the first graduates of the U.S. Quality Algorithms Managed Care Fellowship between U.S. Healthcare and Thomas Jefferson Medical College. Dr. Smith’s interest in medical management led her to pursue a Masters Degree in business administration at the renowned Wharton School of Business where in sixteen months she completed a double major in health care administration and operations management as well as made the Directors List. As the creator of the bimonthly Managed Care Clinical Corner editorial, Dr. Smith was appointed to the editorial board of Disease Management. Dr. Smith has served on the Houston Technology Advisory Board in addition to the GlaxoSmithKline Advisory Board and holds memberships in National Association of Managed Care Physicians, American College of Physician Executives, American Association for the Advancement of Science, Society for Neuroscience, and the Association for Chemoreception Sciences. Additionally, Dr. Smith was a consultant to the Department of Health Policy and the Clinical Outcomes Department at Thomas Jefferson Hospital and the Utilization Department of Methodist Hospital. Dr. Smith has been published extensively dealing with marketing, computer usage in office settings, clinical practice, management and data mining. .

Related Links:
http://www.robinlsmith.com
http://www.ceresliving.com